Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: Patient characteristics and initial response to sulfonylurea therapy

Diabetes

Volumn 53, Issue 10, 2004, Pages 2713-2718

  Sagen, Jørn V ^a   Ræder, Helge ^a   Hathout, Eba ^b   Shehadeh, Naim ^c   Gudmundsson, Kolbeinn ^d   Bævre, Halvor ^e   Abuelo, Dianne ^f   Phornphutkul, Chanika ^g   Molnes, Janne ^a   Bell, Graeme I ^h   Gloyn, Anna L ⁱ   Hattersley, Andrew T ⁱ   Molven, Anders ^a   Søvik, Oddmund ^a   Njølstad, Pål R ^a,j  

^a UNIVERSITY OF BERGEN   (Norway)

^b LOMA LINDA UNIVERSITY HEALTH   (United States)

^c RAMBAM MEDICAL CENTER   (Israel)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e Innlandet Hospital Trust   (Norway)

^f RHODE ISLAND HOSPITAL   (United States)

^g BROWN UNIVERSITY   (United States)

^h UNIVERSITY OF CHICAGO   (United States)

ⁱ PENINSULA MEDICAL SCHOOL   (United Kingdom)

^j HAUKELAND UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCAGON; GLUCOKINASE; HEMOGLOBIN A1C; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENE; GENE MUTATION; HUMAN; INFANT; KCNJ11 GENE; MALE; NEWBORN; ORAL GLUCOSE TOLERANCE TEST; PEDIGREE; PERMANENT NEONATAL DIABETES; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; MALE; PEDIGREE; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN SUBUNITS; SULFONYLUREA COMPOUNDS;

EID: 4644260056     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.10.2713     Document Type: Article

References (15)

1. Polak M, Shield J: Neonatal and very-early-onset diabetes mellitus. Semin Neonatal 9:59-65, 2004
2. Temple IK, Gardner RJ, Mackay DJ, Barber JC, Robinson DO, Shield JP: Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 49:1359-1366, 2000
3. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF: Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 15:106-110, 1997
4. Schwitzgebel VM, Mamin A, Brun T, Ritz-Laser B, Zaiko M, Maret A, Journayvaz FR, Theintz GE, Michielin O, Melloul D, Philippe J: Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1. J Clin Endocrinol Metab 88:4398-4406, 2003
5. Delepine M, Nicolino M, Barret T, Golamaully M, Lahtrop GM, Julier C: EIF2AK3, encoding translation initiation factor-2 alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 25:406-409, 2000
6. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME: X-linked neonatal diabetes mellitus, enteropathy and endocrinopahty syndrome is the human equivalent of mouse scurfy. Nat Genet 27:18-20, 2001
7. Njølstad PR, Søvik O, Cuesta-Munoz A, Bjørkhaug L, Massa O, Barbetti F, Undlien DE, Shiota C, Magnuson MA, Molven A, Matschinsky FM, Bell GI: Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588-1592, 2001
8. Njølstad PR, Sagen JV, Bjørkhaug L, Odili S, Shehadeh N, Bakry D, Sarici SU, Alpay F, Molnes J, Molven A, Sovik O, Matschinsky FM: Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes 52:2854-2860, 2003
9. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sunmik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njølstad PR, Ashcroft FM, Hattersley AT: Activating mutations in the gene encoding the ATP-sensitive potassium channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838-1849, 2004
10. Widness JA, Cowett RM, Zeller WP, Susa JB, Rubenstein AH, Schwartz R: Permanent neonatal diabetes in an infant of an insulin-dependent mother. J Pediatr 100:926-929, 1982
11. ATP channels. Biochem Soc Trans 30:333-339, 2002
12. ATP channels induces profound neonatal diabetes. Cell 100:645-654, 2000
13. Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA: Transgenic knockouts reveal a critical requirement for pancreatic beta-cell glucokinase in maintaining glucose homeostasis. Cell 83:69-78, 1995
14. Seino S, Miki T: Gene targeting approach to clarification of ion channel function: studies of Kir6.x null mice. J Physiol 554:295-300, 2004
15. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT: Genetic cause of hyperglycemia and response to treatment in diabetes. Lancet 362:1275-1281, 2003